Labshake search
Citations for R&D Systems :
151 - 200 of 1327 citations for 4 Chloro 2 fluoro 3' 4 methylpiperazinomethyl benzophenone since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... 25 µg/ml human recombinant Bone Morphogenetic Protein 4 (BMP4, R&D Systems) and 55 µM β-mercaptoethanol (Life technologies) ...
-
bioRxiv - Cancer Biology 2020Quote: ... fibroblasts were treated for 4 days with recombinant human OSM (R&D Systems) at 10 ng/μl or vehicle (PBS ...
-
bioRxiv - Neuroscience 2020Quote: ... Antibodies used to assess pluripotency were anti-OCT3/4 (R&D Systems AF1759), anti-SOX2 (BD 245619) ...
-
bioRxiv - Immunology 2022Quote: ... or 4 μg/mL of anti-CCL1 Ab (clone 148113; R&D Systems), was added to the cultures.
-
bioRxiv - Immunology 2022Quote: ... 4 μg/mL of anti-CCL5 Ab (polyclonal goat IgG; R&D Systems), or 4 μg/mL of anti-CCL1 Ab (clone 148113 ...
-
bioRxiv - Cell Biology 2024Quote: ... 15 ng/mL BMP-4 (314-BP-050/CF; R&D Systems Inc) and 125 ng/mL Fibroblast growth factor (FGF ...
-
bioRxiv - Bioengineering 2024Quote: ... 1 ng/mL human bone morphogenetic protein 4 (Bmp4) (R&D Systems, Inc.), 20 ng/mL human basic fibroblast growth factor (b-FGF ...
-
bioRxiv - Cancer Biology 2023Quote: ... and recombinant human TIM-4-HIS (R&D Systems, Cat# 9407-TM-050)) ...
-
bioRxiv - Bioengineering 2023Quote: ... at 4°C for 16 h and measured via ELISA (R&D Systems). The distribution of TGF-β in Ø2×2 mm and Ø5×2 mm constructs was predicted via FE model (FEBio ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/mL of IL-4 (R&D systems, 402-ML-020)) ...
-
bioRxiv - Bioengineering 2023Quote: ... or 4 µg mL-1 human PDGFR beta antibody (AF385, R&D Systems) and 10 µg mL-1 human/mouse/rat alpha-smooth muscle actin antibody (MAB1420 ...
-
bioRxiv - Immunology 2023Quote: ... with 50 ng/ml of IL-4 (R&D systems, Minneapolis, MN, USA) and 50 ng/ml of GM-CSF (R&D Systems ...
-
bioRxiv - Developmental Biology 2024Quote: ... 50 ng/mL bone morphogenic protein 4 (hBMP4, R&D Systems #314-BP), 10 ng/mL granulocyte colony-stimulating factor (hG-CSF ...
-
bioRxiv - Cell Biology 2024Quote: ... Noggin 50ng/ml (day 0-4, 1967-NG-025/CF, R&D systems), DKK-1 10 ng/ml (day 0-6 ...
-
bioRxiv - Cancer Biology 2022Quote: ... Digested cells were washed three times with PBS and resuspended in 2/3 Cultrex Type 2 (R&D Systems) and 1/3 Full Ad-DF+++ medium and plated in drops which were allowed to solidify for 30 minutes at 37°C after which they were overlayed with Full Ad-DF+++ medium ...
-
bioRxiv - Immunology 2024Quote: ... from 2-3 donors towards CXCL2 (R&D Systems, cat. 276-GB-010) and RARRES2 (R&D Systems ...
-
bioRxiv - Immunology 2021Quote: ... and 1 μg/mL rat anti-mouse IL-4 from R&D Systems (MAB404100) was added ...
-
bioRxiv - Immunology 2021Quote: ... recombinant human IL-4 at 50 ng/ml (R&D Systems, Minneapolis, MN, USA) for 6 h ...
-
bioRxiv - Neuroscience 2020Quote: ... Anti-4-hydroxynonenal antibody was purchased from R&D Systems (MAB3249, Minneapolis, MN 75), while anti-BDNF was purchased from Santa Cruz Biotechnology (sc-546 ...
-
bioRxiv - Molecular Biology 2020Quote: ... Primary antibodies used were anti-IL6 (R&D Systems, 1:100; overnight 4°C), anti-nucleolin (Santa Cruz ...
-
bioRxiv - Developmental Biology 2021Quote: ... 10 ng/mL bone morphometric protein-4 (BMP4, R&D Systems, cat#314-BP), 3 µM CHIR99021 (STEMCELL Technologies ...
-
bioRxiv - Cell Biology 2022Quote: ... 5 μg/ml heparin and 50 ng/ml BMP-4 (#5020BP, R&D System). Seventy-two hours after induction ...
-
bioRxiv - Immunology 2020Quote: ... 4 ng/ml human transforming growth factor α (TGFα; R&D Systems, MN, USA) as a positive control ...
-
bioRxiv - Immunology 2020Quote: ... monocytes were cultured with 250 U/ml IL-4 (R&D Systems, Minneapolis, MN) and 800 U/mL GM-CSF (R&D Systems ...
-
bioRxiv - Microbiology 2020Quote: ... followed by 4 days with 200ng/ml Noggin (R&D Systems, 6057-NG-100), 500ng/ml FGF4 (Peprotech ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 ng mL− 1 BMP-4 (human recombinant) (R&D Systems, Minneapolis, MN, USA), 10 µM LY294002 (Cayman Chemical ...
-
bioRxiv - Neuroscience 2022Quote: Pentraxins Binding C1q Purified recombinant neuronal pentraxin proteins (4 µg/mL, R&D Systems) or IgM (2 µg/mL ...
-
bioRxiv - Pathology 2024Quote: ... and 4 by commercial porcine ELISA kits (R&D Systems, Abingdon, Oxfordshire, United Kingdom) according to the manufacturer’s instructions and expressed as picograms per milligram of wet tissue [13] ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-4 (R&D systems, #204-IL/CF). Inhibitors used were the PI3Kdelta inhibitor Idelalisib ...
-
bioRxiv - Cell Biology 2023Quote: ... followed by treatment with 30 ng/mL each Il-4 (R&D Systems; 404ML010) and IL-13 (R&D Systems ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... Cytokine levels were measured using Mouse IL-4 Quantikine ELISA (M4000B; R&D Systems) and Mouse IL-13 Quantikine ELISA (M1300CB ...
-
bioRxiv - Bioengineering 2023Quote: ... staining for anti-murine Fatty acid binding protein 4 (Fabp4) (R&D Systems, AF1443) was used ...
-
bioRxiv - Immunology 2022Quote: ... IL-4 (50 ng/ml) and TGF-β (5 ng/ml) (R&D Systems) for TH9 cells ...
-
bioRxiv - Immunology 2024Quote: ... or 50 µg/ml LPS and 50 ng/ml rIL-4 (R&D Systems) for 4 days ...
-
bioRxiv - Immunology 2024Quote: ... IL-4 and IL-10 were estimated using commercially available kits (R&D System).
-
Differentiation Protocol-Dependent Variability in hiPSC-Derived Endothelial Progenitor FunctionalitybioRxiv - Bioengineering 2024Quote: ... 30 ng/mL Bone Morphogenic Protein 4 (BMP4, R&D Systems, 314-BP-050), and 0.15 µM 6-bromoindirubin-3-oxime (BIO ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Microbiology 2020Quote: ... cells were pre-treated with IL-4 (200 U/ml) (R&D Systems, Minneapolis, MN) for 12h at 37°C and then stimulated and infected as above ...
-
bioRxiv - Cell Biology 2021Quote: ... and 4 mg/ml Collagen-I (Cultrex 3D rat tail collagen-I, R&D systems) on ice ...
-
bioRxiv - Neuroscience 2022Quote: ... followed by 4 hour incubation with mouse anti-O4 IgM (1:1000; R&D Systems) and rat anti-MBP (1:500 ...
-
bioRxiv - Cell Biology 2024Quote: ... and 50 ng/mL bone morphogenetic protein 4 (BMP4; 314-BP, R&D Systems, USA) on day 1 ...
-
bioRxiv - Neuroscience 2023Quote: ... a 10 μL intramuscular injection of Spp1 neutralizing antibody (4 μg, AF808, R&D Systems) was administered into the tibialis anterior (TA ...
-
bioRxiv - Immunology 2023Quote: ... and 25ng/ml recombinant mouse IL-4 (clone 404-ML-025/CF; R&D System) in final volume of 200 μl of RPMI 1640 medium supplemented with 10% FBS ...
-
bioRxiv - Immunology 2023Quote: ... 2.5% HEPES and stimulated with 50ng/ml IL-4 (R&D Systems Cat: 404-ML) for 15 minutes at 37°C ...
-
bioRxiv - Developmental Biology 2023Quote: ... gfCDM media was supplemented with 5 nM BMP-4 (R&D Systems, #314-BP-050), followed by 1/2 media change on d9 and d12 ...
-
bioRxiv - Neuroscience 2021Quote: ... PlGF-2 (3 – 30 ng; 5 µl; cat.465-PL/CF, R&D System, USA), VEGF-E (3 – 30 ng ...
-
bioRxiv - Cell Biology 2020Quote: ... cells were incubated over night at 4 °C with the anti-CD140a (R&D Systems AF1062) diluted 1:80 in blocking solution ...
-
bioRxiv - Bioengineering 2022Quote: ... were coated with 4 μg ml-1 recombinant mouse IL-10 receptor alpha (R&D Systems) overnight at 4°C ...
-
bioRxiv - Immunology 2021Quote: ... were coated with recombinant human CTLA-4-Fc (7268-CT, R&D Systems, Minneapolis, MN, USA) at 1 μg/mL overnight at 4°C ...
-
bioRxiv - Neuroscience 2020Quote: ... followed by overnight incubation at 4°C in anti-β3 tubulin (1:100, R&D Systems). Sections were rinsed and incubated with goat-anti-mouse Alexa-488 (1:500 ...